Literature DB >> 16240383

Improving case ascertainment of a population-based birth defects registry in New York State using hospital discharge data.

Ying Wang1, Monica Sharpe-Stimac, Philip K Cross, Charlotte M Druschel, Syni-An Hwang.   

Abstract

BACKGROUND: The assessment of the data quality of population-based registration systems is essential to understanding the reliability and usefulness of disease surveillance and research findings resulting from the use of registry data. Since the New York State Congenital Malformations Registry (CMR) uses passive case ascertainment, the completeness of the registry data is an important aspect of the quality of information. This paper presents the results of hospital audits, which were conducted to capture the unreported cases using hospital discharge files, and evaluates the effectiveness of the audits.
METHODS: Children age 2 years or younger and diagnosed with reportable birth defects for the birth years 1998-2000 were selected from hospital discharge files of all reporting hospitals in the New York Statewide Planning and Research Cooperative System (SPARCS) and matched to the CMR database for the same birth year period. The unmatched reports from the SPARCS hospital discharge files that the CMR possibly missed were sent to hospitals, requesting submission of the missed reports. Two audits on all reporting hospitals in New York State were conducted: 1) 1998 and 1999 birth cohorts audited from June 2000 to March 2002, and 2) 2000 birth cohort audited from November 2001 to November 2002.
RESULTS: Hospital audits using SPARCS hospital discharge data identified 5,460 reports that the CMR missed for the selected 66 hospitals analyzed. About 86% of these reports had reportable conditions and were added to the CMR, which comprised 21.4% of all reports from the 66 hospitals for the birth years 1998-2000. The number of reports that would have been missed without audits decreased from the 1998 and 1999 birth cohort (25.1%) to the 2000 birth cohort (13.9%). Low reporting rates and, thus, a high percent of added reports, were found for hospitals with a relatively small number of annual reports and for some specific birth defects such as chromosomal anomalies, anencephalus and congenital anomalies of the urinary system.
CONCLUSION: The current study demonstrates that using hospital discharge data to improve case ascertainment is a valuable and effective method of enhancing birth defect surveillance, particularly for those hospitals with low reporting rates.

Entities:  

Mesh:

Year:  2005        PMID: 16240383     DOI: 10.1002/bdra.20208

Source DB:  PubMed          Journal:  Birth Defects Res A Clin Mol Teratol        ISSN: 1542-0752


  5 in total

1.  Breech presentation at delivery: a marker for congenital anomaly?

Authors:  D Mostello; J J Chang; F Bai; J Wang; C Guild; K Stamps; T L Leet
Journal:  J Perinatol       Date:  2013-10-24       Impact factor: 2.521

2.  Evaluation of three algorithms to identify incident breast cancer in Medicare claims data.

Authors:  Heather T Gold; Huong T Do
Journal:  Health Serv Res       Date:  2007-10       Impact factor: 3.402

3.  Combining adverse pregnancy and perinatal outcomes for women exposed to antiepileptic drugs during pregnancy, using a latent trait model.

Authors:  Xuerong Wen; Abraham Hartzema; Joseph A Delaney; Babette Brumback; Xuefeng Liu; Robert Egerman; Jeffrey Roth; Rich Segal; Kimford J Meador
Journal:  BMC Pregnancy Childbirth       Date:  2017-01-06       Impact factor: 3.007

4.  Copy-number variants and candidate gene mutations in isolated split hand/foot malformation.

Authors:  Tonia C Carter; Robert J Sicko; Denise M Kay; Marilyn L Browne; Paul A Romitti; Zoё L Edmunds; Aiyi Liu; Ruzong Fan; Charlotte M Druschel; Michele Caggana; Lawrence C Brody; James L Mills
Journal:  J Hum Genet       Date:  2017-05-25       Impact factor: 3.172

5.  Prevalence and Clinical Attributes of Congenital Microcephaly - New York, 2013-2015.

Authors:  Krishika A Graham; Deborah J Fox; Achala Talati; Cristian Pantea; Laura Brady; Sondra L Carter; Eric Friedenberg; Neil M Vora; Marilyn L Browne; Christopher T Lee
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2017-02-10       Impact factor: 17.586

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.